Referred to the House Committee on Energy and Commerce.
This bill amends the Federal Food, Drug, and Cosmetic Act to add galactose-alpha-1,3-galactose ("alpha-gal") to the statutory definition of a "major food allergen." It explicitly includes ingredients derived from non-catarrhine primate mammals and red algae in the order Gigartinales, and excludes mammal-derived ingredients for which the Secretary determines alpha-gal is below a detectable limit. The amendment would take effect 18 months after enactment.
Left emphasizes consumer safety; right emphasizes regulatory burden.
Relative to its intended legislative type, this bill is a straightforward statutory amendment that clearly accomplishes the primary legal change intended—adding galactose-alpha-1,3-galactose (alpha-gal) to the FD&C Act definition of a major food allergen—with a short definitional text, a narrow set of inclusions and one exclusion, and an 18-month delayed effective date.
This bill amends the Federal Food, Drug, and Cosmetic Act to add galactose-alpha-1,3-galactose ("alpha-gal") to the statutory definition of a "major food allergen." It explicitly includes ingredients derived from non-catarrhine primate mammals and red algae in the order Gigartinales, and excludes mammal-derived ingredients for which the Secretary determines alpha-gal is below a detectable limit.
The amendment would take effect 18 months after enactment.
Targeted, low-ideological change with precedent for adding allergens, but industry pushback and procedural hurdles reduce odds.
Relative to its intended legislative type, this bill is a straightforward statutory amendment that clearly accomplishes the primary legal change intended—adding galactose-alpha-1,3-galactose (alpha-gal) to the FD&C Act definition of a major food allergen—with a short definitional text, a narrow set of inclusions and one exclusion, and an 18-month delayed effective date.
Left emphasizes consumer safety; right emphasizes regulatory burden.
These are examples from the analysis, not a ranked list of the most-affected groups.
Left emphasizes consumer safety; right emphasizes regulatory burden.
Likely supportive because the bill expands consumer protections for people with food allergies by requiring clearer labeling.
Supporters would view it as a public-health measure that reduces risk and promotes informed choice for vulnerable consumers.
Cautious support contingent on implementation details.
The centrist view sees public-health benefits but wants clear, evidence-based thresholds, predictable enforcement, and reasonable compliance timelines to limit unintended costs.
Likely skeptical or opposed due to added regulatory burden and costs for food producers.
Concerns would focus on scope, unclear definitions, and federal expansion into labeling with potentially limited public-health returns.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Targeted, low-ideological change with precedent for adding allergens, but industry pushback and procedural hurdles reduce odds.
The bill has not accumulated any surfaced votes yet.
Left emphasizes consumer safety; right emphasizes regulatory burden.
Targeted, low-ideological change with precedent for adding allergens, but industry pushback and procedural hurdles reduce odds.
Relative to its intended legislative type, this bill is a straightforward statutory amendment that clearly accomplishes the primary legal change intended—adding galactose-alpha-1,3-galactose (alpha-gal) to the FD&C Act…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.